Canada-US Roundtable on Strategies to Combat the Opioid Crisis
September 24, 2018
Event Overview and Agenda
The Canada-U.S. relationship is one that is unique in the world, marked by a shared border, common values and deep economic, security and cultural ties. Unfortunately, in recent years our two nations have begun to share a devastating trend: the rise in opioid-related deaths and opioid substance use disorders.
Canada and the United States benefit from substantial coordination in other shared priorities: public health surveillance in emerging infectious disease, border security, and traceability in other sectors.
There is great potential to build upon and expand existing relationships within each government to address this growing crisis, along with a broader community of stakeholders on both sides of the border. To this end, the Canada-U.S. Roundtable will assemble federal and state health professionals, members from law enforcement communities, policy makers and advocates from both countries.
The goals of the event are the following:
1. Exchange best practices in innovation to address problematic opioid use, including prevention, treatment and recovery.
2. Identify opportunities for collaboration, such as surveillance, research, training, and standards.
Ultimately, the Roundtable could help encourage greater collaboration and cooperation between each country to confront this urgent issue in public health.
Event timing and location
The event will take place on September 24th, 2018 in Washington D.C. at The Pew Charitable Trusts, 901 E Street NW.
Panel 1: The Opioid Crisis: Views from the Ground and 10,000 Feet
Facilitated by Stephen Morrison, PhD, Senior Vice President and Director, Global Health Policy Center
- Mitch Wolfe, MD, MPH, Director (interim), Center for Disease Control, Washington Office
- Senior Health Officer, Health Canada (invited)
Christopher Jones, Pharm. D., Director, National Mental Health and Substance Use Policy Laboratory, U.S. Substance Abuse and Mental Health Services Administration (SAMHSA)
Panel 2: The Bright Lights: Innovation in Prevention, Treatment and Recovery
Facilitated by Anne Snowdon, PhD. Academic Chair, World Health Innovation Network, Scientific Director and CEO, SCAN Health
- Nicole Alexander-Scott, MD, MPH, Executive Director, Rhode Island Department of Health
- Ann Griepp, MD, Chief Medical Officer, Excellus BlueCross BlueShield, Project ECHO
- Karen Grimsrud, MD, Chief Medical Officer of Health, Province of Alberta
- Robert Strang, MD, Chief Medical Officer, Province of Nova Scotia
- Barbara Bazron, PhD, Deputy Secretary and Executive Director, Behavioral Health, State of Maryland and Clay Stamp, Executive Director, Opioid Operational Command Center, Senior Emergency Advisor, State of Maryland
This session will bring forward the perspective of individuals with lived experience with substance and opioid addiction and recovery, to engage Roundtable participants on personal stories and provide meaning to Canada-U.S. dialogue on the opioids crisis.
Facilitated by Tom Hill, Vice President of Practice Improvement, The National Council for Behavioral Health
The Roundtable will hold two concurrent breakout sessions, and attendees will have the option to select their preferred breakout session while registering for the event. Each breakout session will identify and note opportunities for further Canada-U.S. collaboration beyond the event.
Breakout Session 1
1a. Fostering Cross-Border Coordination between Public Health and Law Enforcement: Case Examples and a Way Forward
a) How are public health and law enforcement authorities currently working together to address common priorities, with respect to the opioid crisis?
b) Canadian and U.S. public health officials have demonstrated close coordination in areas such as emerging infectious disease. How could existing Can-U.S. coordination in public health be applied to address common priorities under the opioid crisis?
c) What are the opportunities and obstacles to fostering greater Canada-U.S. cross-coordination and information-sharing between public health and law enforcement?
Facilitated by Regina LaBelle, Principal, LaBelle Strategies
- Allie Hunter McDade, Executive Director, Police Assisted Addiction and Recovery Initiative, Gloucester, Massachusetts
- Scott Allen, Chief of Police, East Bridgewater, Massachusetts
- Michael Botieri, Chief of Police, Plymouth, Massachusetts
- Bill Spearn, Inspector, Vancouver Police Department
- Stephen McConachie, Chief Operations Manager, U.S. Customs and Border Protection Agency
- Van Ingram, Executive Director, Office of Drug Control Policy, State of Kentucky
1b. Primary Prevention, Secondary Prevention and Treatment: Applying Lessons Learned
a) What are the lessons learned from promoting non-opioid treatment options and medication-assisted treatment for opioid use disorder?
b) How are health systems working together with prescribers to encourage appropriate prescribing and the expansion of medication-assisted treatment (both in Canada and the U.S.)?
Facilitated by Allan Coukell, Senior Director, Health Programs, The Pew Charitable Trusts
- Norm Buckley, MD, Chair, Department of Anesthesia, Scientific Director, Michael G. DeGroote Institute for Pain Research and Care, McMaster University
- Tom Hill, Vice President of Addiction and Recovery, National Council for Behavioral Health
- Seonaid Nolan, MD, Clinical Researcher, British Columbia Centre on Substance Use
- Two additional panelists to be announced shortly.
Breakout Session 2
2a. Access to Care and Population Health: A Perspective from Rural and Urban Communities
a) What novel approaches are being used to better service needs of rural communities?
b) How can we apply successes from urban settings to rural settings?
c) How are we examining the underlying causes that lead to addiction, and considering social determinants of health?
d) What are best practices with respect to social housing and treatment support?
Facilitated by Michael Petersen, MD, Health Innovation Lead, Accenture Health and Public Services
Jay Butler, MD, Chief Medical Officer, State of Alaska
Kathryn Dong, MD, Director, Addiction Recovery Community Health Team (ARCH) and Inner-City Health and Wellness, Alberta
Bonnie Henry, MD, Provincial Health Officer, Province of British Columbia
Lipi Roy, MD, MPH, Medical Director, Addiction Treatment Center, New York State Office of Alcoholism and Substance Abuse
Steve Williams, Mayor, Huntington, West Virginia
2b. Data, Surveillance and Research: Where We Are At, and Where We Need to Be
a) What are the benefits and challenges associated with establishing standards for data collection, monitoring, sharing and research?
b) What informatics tools are being utilized to address the opioids crisis?
c) What are the lessons learned and way forward for Prescription Drug Monitoring? How can Canada and the United States work together to promote greater data sharing, research etc.?
d) What other kinds of data and information are critical for ensuring an effective opioid response?
Facilitated by Michael Green, CEO, Canada Health Infoway
- Jessica Halverson, Director, Opioid-Related Harms, Centre for Surveillance and Applied Research, Public Health Agency of Canada
Elaine Hyshka, PhD, Assistant Professor, School of Public Health, University of Alberta; and Scientific Director, Inner City Health and Wellness Program, Royal Alexandra Hospital
Steve Kearney, Pharm. D., Medical Director, SAS Institute
Alana Vivolo, National Center for Injury Prevention and Control (NCIPC), U.S. Centers for Disease Control and Prevention